Medicare Compliance & Reimbursement
OIG To CMS--51 Drugs May Be Overpriced
A few dozen Part B drugs could be facing steep drops in their already-low reimbursements soon.
The law gives the Centers for Medicare & Medicaid Services the authority to slash drug payments if the average sales price (ASP) is at least 5 percent higher than the average price the manufacturer actually charges. Medicare pays for Part B drugs based on ASP plus 6 percent.
And the HHS Office of Inspector General's latest report says that 51 drugs had ASPs that were at least 5 percent higher than manufacturer prices, if you use CMS's method of calculating ASPs. If you use the OIG's preferred method, only 38 drugs were over by 5 percent or more. Some 34 drugs met the threshold, whichever method you use.
But CMS isn't going to leap to make any changes to ASPs in response to the OIG's report. CMS responded that the OIG was using data from the early stages of the ASP pricing system, and most of the overestimates the OIG found have disappeared by now.
Medicare Compliance & Reimbursement
- PHYSICIANS:
Consult Confusion Just Got More Tangled
You don't have to verify documentation, but it should be there.
You've been tearing out your [...] - CODING:
Reap The Rewards For VAC Wound Care Now
Physicians can bill for 97605-97606.
Cutting-edge wound care technology will now receive the reimbursement it deserves.
Heads [...] - COPAYMENTS:
Don't Write Off Low-Income Copays Until You Get The Facts
Good news: Your state may cover copays, even for non-Medicaid patients.
If your practice sees a [...] - PRESCRIPTION DRUGS:
OIG To CMS--51 Drugs May Be Overpriced
CMS disputes OIGs calculations, however.
A few dozen Part B drugs could be facing steep drops [...] - INCIDENT-TO-BILLING:
Pre-2002 Incident-To Claims Could Still Wind Up In Court
Now is the time to scrutinize your documentation.
Ignorance of the incident-to law is no excuse--even [...] - HHAs:
CMS Piles On ABN Burdens In New Q & A
You still have to issue an ABN if the reduction is included in the recent [...] - DME SUPPLIERS:
Strategic Planning Tips Help DME Players Stay In The Game
Clues in proposed bidding rule can help you prepare.
The feds continue to wrestle with the [...] - INDUSTRY NOTES:
CMS May Be Just Going Through The CAP Motions
Plus: Medicare defrauder loses medical license, title.
The Centers for Medicare & Medicaid Services finally issued [...]
